לבופד ישראל - עברית - Ministry of Health

לבופד

pfizer pfe pharmaceuticals israel ltd - norepinephrine bitartrate as monohydrate - תמיסה להזרקה - norepinephrine bitartrate as monohydrate 2.0 mg / 1 ml - norepinephrine - norepinephrine - blood pressure control in certain acute hypotensive stages (e.g. pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infraction, septicemia, blood transfusion and drug reactions). as an adjunct in the treatment of cardiac arrest and profound hypotension.

טאזופיפ 4.5 גרם ישראל - עברית - Ministry of Health

טאזופיפ 4.5 גרם

perrigo israel agencies ltd - piperacillin as sodium 4000 mg; tazobactam as sodium 500 mg - powder for solution for injection - piperacillin - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. tazo-pip in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

טאזופיפ 4.5 גרם ישראל - עברית - Ministry of Health

טאזופיפ 4.5 גרם

perrigo israel agencies ltd - piperacillin as sodium 4000 mg; tazobactam as sodium 500 mg - powder for solution for injection - piperacillin - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. tazo-pip in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

טאזופיפ 2.25 ג' ישראל - עברית - Ministry of Health

טאזופיפ 2.25 ג'

perrigo israel agencies ltd - piperacillin as sodium 2000 mg; tazobactam as sodium 250 mg - powder for solution for injection - piperacillin and enzyme inhibitor - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. tazo-pip in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

טאזופיפ 2.25 ג' ישראל - עברית - Ministry of Health

טאזופיפ 2.25 ג'

perrigo israel agencies ltd - piperacillin as sodium 2000 mg; tazobactam as sodium 250 mg - powder for solution for injection - piperacillin and enzyme inhibitor - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. tazo-pip in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

דוסטאקסל הוספירה 10 מגמל ישראל - עברית - Ministry of Health

דוסטאקסל הוספירה 10 מגמל

pfizer pfe pharmaceuticals israel ltd - docetaxel - תמיסה לאינפוזיה - docetaxel 10 mg / 1 ml - docetaxel - docetaxel - breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress her2 and who previously have not received chemotherapy for metastatic disease. docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracyclin

אוקסליפלטין הוספירה 5 מ"ג/מ"ל - 50 מ"ג ישראל - עברית - Ministry of Health

אוקסליפלטין הוספירה 5 מ"ג/מ"ל - 50 מ"ג

novapharma ltd - oxaliplatin 50 mg/vial - powder for solution for infusion - oxaliplatin - oxaliplatin in combination with 5- fluorouracil and folinic acid (fa) is indicated for : - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour .- treatment of metastatic colorectal cancer.

אוקסליפלטין הוספירה 5 מ"ג/מ"ל - 100 מ"ג ישראל - עברית - Ministry of Health

אוקסליפלטין הוספירה 5 מ"ג/מ"ל - 100 מ"ג

novapharma ltd - oxaliplatin 100 mg/vial - powder for solution for infusion - oxaliplatin - oxaliplatin in combination with 5- fluorouracil and folinic acid (fa) is indicated for : - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour.- treatment of metastatic colorectal cancer.

אוקסליפלטין הוספירה 5 מ"ג/מ"ל ישראל - עברית - Ministry of Health

אוקסליפלטין הוספירה 5 מ"ג/מ"ל

novapharma ltd - oxaliplatin 5 mg/ml - concentrate for solution for infusion - oxaliplatin - in combination with 5- fluorouracil and folinic acid (fa) oxaliplatin is indicated for: - adjuvant treatment of stage iii ( duke's c) colon cancer after complete resection of primary tumour - the treatment of metastatic colorectal cancer.

אירינוטקאן זריקות 20 מ"ג/מ"ל ישראל - עברית - Ministry of Health

אירינוטקאן זריקות 20 מ"ג/מ"ל

novapharma ltd - irinotecan (trihydrate) hydrochloride 20 mg/ml - concentrate for solution for infusion - irinotecan - irinotecan is indicated for the treatment of patients with metastatic colorectal cancer: - in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. - as a single agent in patients who have failed an astablished 5-fluorouracil containing treatment regimen. for the treatment of patients with small cell lung cancer. for the treatment of patients with gastric cancer.